3 February 2026 - Top Stories

Australia sharpens its AI backbone for health tech without the hype. A national project is moving into its second phase to tailor the OECD AI Classification Framework for the sector.

The Digital Health Cooperative Research Centre, the University of Technology Sydney and Ausintelli Technology have kicked into phase two, following phase one which localised the framework for Australian SMEs and delivered a prototype web tool for quick AI categorisation in healthcare. The next stage will refine the tool, introduce a logic-based matrix for granular AI classification in clinical settings, and update the framework to reflect current regulatory and practical needs.

Separately, momentum on interoperability is growing. An independent review of the Sparked Program, the HL7 FHIR accelerator, backs a national FHIR Standards Roadmap. The finding argues the roadmap would give stakeholders confidence to invest across multi-year horizons as products and markets mature, shaping how data moves across health systems.

Industry and consultants are also advocating for HealthCare+ governance, an expanded framework that covers clinical, care, technology and enterprise governance. The concept recognises that care and technology are closely linked and would bring data and non-clinical considerations into governance and board oversight for health tech players in Australia.

In the clinical frontier, Australia will host a world-first trial of personalised cancer vaccines for children with advanced or treatment-resistant brain tumours. Led by the University of Queensland and the South Australian Health and Medical Research Institute, with Providence Therapeutics supplying the mRNA platform, the government has allocated AUD 2.578 million from the Medical Research Future Fund to the PaedNEO VAX study. Vaccines will be customised for each child and manufactured in Queensland, dosing across eight paediatric sites.

Policy and equity considerations are also bubbling up as digital health expands in the region. APAC strategies struggle to translate commitments on gender equality and human rights into concrete plans, a gap that Australia may address through funding, procurement and monitoring aligned with equity indicators as telehealth scales.

• Phase two of Australia’s AI governance project to refine the tool and add a logic-based clinical classification matrix.
• Localisation improvements for SMEs and updated regulatory alignment within the AI framework.
• Independent support for a national HL7 FHIR roadmap to boost interoperable health data.
• HealthCare+ governance concept expanding oversight to technology, data and enterprise governance.
• AUD 2.578 million government funding for the PaedNEO VAX personalised mRNA brain tumour vaccine trial, with domestic manufacturing.
• APAC equity considerations driving Australia to tie funding, procurement and monitoring to equity indicators as telehealth adoption grows.